Primary central nervous system lymphoma prevention

Jump to navigation Jump to search

Primary central nervous system lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Primary Central Nervous System Lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Primary central nervous system lymphoma prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Primary central nervous system lymphoma prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Primary central nervous system lymphoma prevention

CDC on Primary central nervous system lymphoma prevention

Primary central nervous system lymphoma prevention in the news

Blogs on Primary central nervous system lymphoma prevention

Directions to Hospitals Treating Primary central nervous system lymphoma

Risk calculators and risk factors for Primary central nervous system lymphoma prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

There are no primary or secondary preventive measures available for seminoma.

Prevention

There are no primary or secondary preventive measures available for seminoma.

References


Template:WikiDoc Sources